Vector Space Biosciences Price

Vectorspace AI provides correlation matrix datasets to help researchers accelerate data-driven innovation and discoveries using patent-protected natural language processing and understanding (NLP/NLU). Founded in 2020, the company shot into the limelight during the COVID-19 pandemic when it released a thematic basket of stocks correlated to COVID-19, resulting in significant gains.

Vectorspace AI is a subsidiary of Vector Space Biosciences and provides datasets for machine learning and artificial intelligence applications. It includes datasets and associated products that facilitate the construction of systems capable of identifying apparent and concealed relationships within data.

The company’s datasets allow the creation of clusters of entities that possess both evident and concealed connections to external events, worldwide trends, or news. These clusters can represent networks of suppliers, companies developing analogous drugs, or any entity with a symbiotic, parasitic, or sympathetic latent association with another entity, event, or global tendency.

VXV is the native cryptocurrency of the Vectorspace AI platform and has a total supply of 50 million tokens. It provides security, governance, data lineage, and provenance for its datasets.

Vectorspace AI generates datasets using language modeling and scientific data engineering processes, focusing on context-controlled Natural Language Processing/Understanding (NLP/NLU) and feature engineering. The platform’s algorithms can generate datasets that power AI/NL systems across multiple industries - from healthcare and financial services to space and deep tech.

This enables researchers and data scientists to accelerate their data-driven innovation and discoveries by quickly testing hypotheses and running experiments with higher throughput. The company also generates data on thematic investment in the traditional stock market, helping investors spot investment opportunities by analyzing macroeconomic patterns.

Vectorspace AI also supports thematic investing, a concept that has the potential to revolutionize crypto and traditional financial markets. The company’s datasets can generate thematic baskets of traditional market equities.

The company has created language models from scratch and developed scientific data engineering pipelines encompassing data visualization, interpretation, and human-in-the-loop curation. Vectorspace AI’s team has been collaborating with partners for over two decades. It aims to advance scientific research and generate new hypotheses and novel discoveries rapidly with the help of AI and ML technologies.

The history of Vectorspace AI can be traced back to 1997 when NASA commissioned Bissell Lab at Lawrence Berkeley National Laboratory to write a report on safeguarding the human body during a planned mission to Mars. The founding team worked on this initiative and was granted several patents.

They founded the company Vectorspace AI in 2017. In 2020, the company received significant attention when it released a thematic basket of stocks correlated to the COVID-19 pandemic, helping investors realize substantial gains.

In 2021, the company established Vector Space Biosciences and formed an award-winning Scientific Advisory Board (SAB). In 2022, it published its work in partnership with the Imperial College of London (ICL) in a report titled ‘From Markets to Molecules.’

The report examined a technique to find hidden connections between stocks and shares and applied them to discovering and mapping connections between proteins. Leveraging AI and natural language understanding, the technique was used in academic literature to reveal a map showcasing the evolution of observed correlation between two proteins over time.

In August 2022, the company announced the development of a computational solutions platform focused on protecting and repairing the human body during spaceflight.